Only seven percent of American adults have good cardiometabolic health
Most U.S. adults rate poorly across five components of cardiometabolic health, with clear racial disparities. …
Discovery of key heart repair hormone
Study shows that a class of steroid hormones, glucocorticoids, play a key role in regulating the proliferative and regenerative capacity of heart muscle cells. …
Cold temperatures may help combat obesity and related metabolic diseases by reducing inflammation
Exposure to cold temperatures resolved obesity-induced inflammation while improving insulin sensitivity and glucose tolerance in obese mice. …
Environmental factors predict risk of premature death
Along with high blood pressure, diabetes, and smoking, environmental factors such as air pollution are highly predictive of risk of premature death, especially from heart attack and stroke. …
Are vitamins and dietary supplements a waste of money?
Americans in 2021 spent close to $50 billion on vitamins and dietary supplements, but there is insufficient evidence of their effectiveness in preventing cardiovascular disease and cancer. …
Lack of diversity of gut microbiome or elevated metabolite implicated in heart failure severity
Heart failure patients have less diversity in their gut microbiome or have elevated levels of the harmful gut metabolite, trimethylamine-N-oxide (TMAO). …
Nordic walking improves functional capacity in people with heart disease
Nordic walking provides better long-term improvement of functional capacity than other forms of exercise in cardiovascular rehabilitation. …
Stress accelerates immune aging
Stress accelerates aging of the immune system, potentially increasing a person’s risk of cancer, cardiovascular disease and illness from infections such as COVID-19. …
About 3 grams a day of omega-3 fatty acids may lower blood pressure
About 3 grams daily of omega-3 fatty acids, consumed in foods or supplements, appears to be the optimal daily dose to help lower blood pressure. …
Epigenetic markers predict complications in patients with type 2 diabetes
There are distinct epigenetic differences between different groups of type 2 diabetes patients and the epigenetic markers are also associated with different risks of developing common complications. …
End of content
End of content